| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 2552336 | Life Sciences | 2009 | 7 Pages | 
Abstract
												These results suggest that fucoidan acts like heparin by releasing LPL in addition to increasing the intracellular transport and decreasing the degradation of LPL in the medium. Furthermore, LPL and ApoC-II secretion induced by fucoidan may be involved in regulating plasma triglyceride lowering clearance.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Cardiology and Cardiovascular Medicine
												
											Authors
												Takashi Yokota, Mikio Nagashima, Mohammad Ghazizadeh, Oichi Kawanami, 
											